Jürgen Hummel

Vice President, Innovative Statistics

Jürgen Hummel has been working in Biostatistics in the CRO, pharmaceutical, and health care industry since 1995. He has held various project-related, technical, and managerial positions with increasing seniority over the years, and he has experience in a wide range of therapeutic areas, particularly in early and late-stage oncology trials. Over the last 9 years, he headed up the Statistical Methodology groups at PPD and most recently at Novo Nordisk. In his role at Cytel, he provides statistical consultancy, which was an important part of his role in previous jobs as well.

Jürgen has shaped cross-industry collaborations for many years: he led the PSI/EFSPI Regulatory Special Interest Group for the last 5 years, is a member of the EFSPI Statistical Methods Leaders Group, and previously served on the PSI Board of Directors. He is passionate about adaptive designs and was EFPIA Deputy Topic Lead on the ICH E20 Expert Working Group on adaptive design for clinical trials until recently. He earned the German equivalent of an MSc in mathematics and economics at Augsburg University, and he is a Chartered Statistician with the Royal Statistical Society.